US Food and Drug Administration officials expect coronavirus vaccine trials to maintain placebo controls even after an emergency use authorization to ensure multiple candidates still can be cleared.
In a New England Journal of Medicine article published on 16 October, Philip Krause and Marion Gruber, deputy director...







